HealthAstraZeneca's Lynparza Could Be Transformed Into Precision Medicine For Prostate Cancer Following the development of a three-in-one blood test, AstraZeneca's drug Lynparza could be transformed into precision medicine for prostate cancer, experts said. Doing so could have a major impact in the treatment of prostate cancer patients.by Alyssa Navarro
HealthFidget Spinners: Popular Toy Marketed To Help Kids With ADHD Poses Choking Hazardsby Allan Adamson
HealthTop Members In Trump's HIV/AIDS Advisory Council Resign Because 'Trump Doesn't Care About HIV'by Alyssa Navarro
HealthColorado Campaign Wants To Ban Sale Of Smartphones For Children Below 13 Years Oldby Allan Adamson